Vol 24, No 2 (2017)
Letters to the Editor — Interventional cardiology
Published online: 2017-04-14
“Full Plastic-Jacket“: Reconstruction of 18 cm of coronary arteries with bioresorbable vascular scaffolds in a young patient with ST-elevation myocardial infarction and multivessel disease
Abstract
Not available
Keywords: Full Poly-L-lactide JacketBioresorbable vascular scaffoldsmultivessel disease
References
- Lu C, Filion KB, Eisenberg MJ. The safety and efficacy of absorb bioresorbable vascular scaffold: A systematic review. Clin Cardiol. 2016; 39(1): 48–55.
- Puricel S, Cuculi F, Weissner M, et al. Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors. J Am Coll Cardiol. 2016; 67(8): 921–931.
- Widimsky P, Petr R, Tousek P, et al. One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study. Circ Cardiovasc Interv. 2015; 8(12): e002933.
- Jaguszewski M, Ghadri JR, Zipponi M, et al. Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios. Clin Res Cardiol. 2015; 104(2): 124–135.
- Alfonso F, Byrne RA, Rivero F, et al. Current treatment of in-stent restenosis. J Am Coll Cardiol. 2014; 63(24): 2659–2673.
- Gogas BD, King SB, Samady H. Bioresorbable polymeric scaffolds for coronary revascularization: Lessons learnt from ABSORB III, ABSORB China, and ABSORB Japan. Glob Cardiol Sci Pract. 2015; 2015(5): 62.
- Ielasi A, Cortese B, Varricchio A, et al. RAI registry investigators. Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre "Registro ABSORB Italiano" (RAI registry). EuroIntervention. 2015; 11(2): 157–162.
- Imori Y, D'Ascenzo F, Gori T, et al. Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry. Cardiol J. 2016; 23(4): 374–383.
